Metairie, Louisiana Clinical Trials
A listing of Metairie, Louisiana clinical trials actively recruiting patient volunteers.
A Dose Escalation Study to Evaluate Safety Reactogenicity and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive
The primary objectives of this study are to evaluate the tolerability and reactogenicity of a single injection of 1 of up to 5 dose levels of mRNA-1345 in younger adults, women of child-bearing potential, and older adults; of 3 injections of the middle dose level of mRNA-1345 given 56 days …
- 8 views
- 04 Jul, 2021
- +20 other locations
Evaluate the safety and tolerability of AMG 509 in adult subjects and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D).
- 94 views
- 08 Sep, 2021
- +33 other locations
Study RGX-104-001 is a Phase 1, first-in-human, dose escalation and expansion study of RGX-104, an oral small molecule targeting the liver X receptor (LXR), as a single agent and in combination with nivolumab, ipilimumab, docetaxel, or pembrolizumab plus carboplatin/pemetrexed. RGX-104 activates LXR, resulting in depletion of both myeloid-derived suppressor cells …
- 502 views
- 12 Feb, 2021
- +23 other locations
This is a Phase 1 cohort, dose-escalation, dose-expansion study of PRT543 in patients with advanced cancers who have exhausted available treatment options. The purpose of this study is to define a safe dose and schedule to be used in subsequent development of PRT543.
- 80 views
- 07 Aug, 2021
- +22 other locations
This study will evaluate the safety, pharmacokinetics, and pharmacodynamic effects of a novel anti-cancer drug, GZ17-6.02 administered to patients with advanced solid tumors or lymphoma, which have progressed after receiving standard/approved therapy or where there is no approved therapy.
- 29 views
- 08 May, 2021
- +2 other locations
The purpose of this study is to assess the safety and tolerability of ASP9801 and to determine the recommended phase 2 dose (RP2D). The study will also evaluate antitumor activity, objective response rate, pharmacokinetics and virus shedding of ASP9801.
- 18 views
- 17 Sep, 2021
- +19 other locations
SHP655 is a medicine used to treat sickle cell disease (SCD). The main aim of the study is to measure the safety and tolerability of SHP655 in SCD participants. Study participants will receive SHP655 or placebo on Day 1. Their SCD will be treated by their doctor according to their …
- 75 views
- 30 Aug, 2021
- +14 other locations
A safety study of KAN-101 in patients with celiac disease. The study has two parts: Part A - first in human study in which patients receive a single dose of KAN-101 Part B - patients will receive three doses of either KAN-101 or placebo
- 68 views
- 08 Aug, 2021
- +12 other locations
Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy
This is a Phase 1 study designed to test the tolerability and feasibility of intravesical therapy with an attenuated Measles virus (MV-NIS) in patients with urothelial carcinoma who are undergoing radical cystectomy but are ineligible or do not desire neoadjuvant chemotherapy.
- 8 views
- 27 Jun, 2021
- +2 other locations
Pembrolizumab in Treating Patients With HIV and Relapsed Refractory or Disseminated Malignant Neoplasms
This phase I trial studies the side effects of pembrolizumab in treating patients with human immunodeficiency virus (HIV) and malignant neoplasms that have come back (relapsed), do not respond to treatment (refractory), or have distributed over a large area in the body (disseminated). Immunotherapy with monoclonal antibodies, such as pembrolizumab, …
- 142 views
- 16 Aug, 2021
- +4 other locations